London:
- 2 May 2012
New collaboration to support omigapil clinical trial for congenital muscular dystrophy Santhera Pharmaceuticals have announced a collaboration that will help to facilitate the smooth transition of omigapil from the laboratory through to the clinic. - 23 November 2011
London Meet Up - Saturday 26th November Disability Horizons are organising a social meet up in London this Saturday - 10 November 2011
Working with Great Ormond Street Hospital to improve neuromuscular services Last week, the Muscular Dystrophy Campaign met with Dr Jane Collins, Chief Executive of Great Ormond Street Hospital to discuss how we can support them as they develop their neuromuscular services - 9 November 2011
Driving forward service improvements in London Today the Muscular Dystrophy Campaign discussed services in London at a meeting with Lord Walton and Dr Andy Mitchell, Medical Director at NHS London - 17 May 2011
Have your say in our hospital survey To fight for further investment in specialist neuromuscular services we really need your help, by filling in our new survey, so that we can gather evidence regarding the care that you or someone close to you receives in hospital. - 11 May 2011
NHS wastes £31 million a year The Muscular Dystrophy Campaign’s Invest to Save report, launched in Parliament today, reveals that the NHS is wasting £31 million each year on unplanned emergency admissions to hospital for muscle disease patients. - 18 April 2011
A Marathon Effort In glorious sunshine on Sunday 110 fabulous runners completed a grueling 26 miles and are on their way to raising an amazing £200,000 for the Muscular Dystrophy Campaign. - 19 November 2010
Trailblazers evidence featured in new report on London’s transport network A new report by the London Assembly Transport Committee, based on evidence provided by Trailblazers campaigners, was launched today. - 29 October 2010
Myostatin exon skipping shows promise for a wide range of muscle conditions Research part-funded by the Muscular Dystrophy Campaign has shown it is possible to use exon skipping to control the activity of myostatin - an approach that could be used to treat a range of muscle diseases. - 19 October 2010
Specialised Commissioning in All Party Group spotlight MPs and Peers in the All Party Parliamentary Group for Muscular Dystrophy put pressure on national and regional health bosses in Parliament today to implement neuromuscular service improvements.
